HIGHLIGHTS
- who: Cerebrospinal Fluid and colleagues from the Germany, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University, Frankfurt, Germany, Forenap Pharma, Rouffach, France have published the Article: Metabolite Profiling of Alzheimer’s Disease Cerebrospinal Fluid, in the Journal: (JOURNAL) of February/16,/2012
- what: The aim of this study was to identify the metabolic changes resulting from the disease phenotype by a thorough and systematic metabolite profiling approach. The authors show the metabolic profile in human CSF samples of AD patients and age-matched healthy controls. This approach attempts to identify candidates for biomarkers traced . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.